ArticleInvestigational new drugs2019

Lurbinectedin (PM01183), a selective inhibitor of active transcription, effectively eliminates both cancer cells and cancer stem cells in preclinical models of uterine cervical cancer.

Eriko Yokoi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.